Delhi High Court ruled that expenditure cannot be disallowed under Section 14A unless exempt income is actually earned in the relevant ...

Ministry of Defence's target of Rs 3 trillion in capital outlay by CY29 underscores the government's commitment to military ...

When the Supreme Court declined to hear HMTX Industries v. U.S. last month, it appeared to close the book on the legality of ...

(NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that it will receive a $24.5 ...

Here is what readers need to know about Georgia's special session that will convene Wednesday, June 17, to redraw the state's political maps for 2028 and more.

United States President Donald Trump says he’s relaxing tariffs on certain products that use steel, aluminum and copper, such as agricultural machinery and HVAC equipment, to 15 per cent from 25 to ...

[L.-R.]: Kyusik Kim, PhD, senior scientist I; Arnold Sengooba, MS, associate scientist; and Elizabeth (Eli) Fajardo Brigido, MS, senior research associate, all of Serif Biomedicines, discuss an ...

Multinational administrative cohorts (France, British Columbia) matched incident cancer cases with MS 1:2 to controls, evaluating MS-related care utilization across two years before and after first ...

Much of the challenge in developing cancer therapies is determining methods to improve the effectiveness of the immune system’s ability to identify and kill cancer cells. While therapies like CAR T ...

A state appellate court ruling striking down New York’s ban on Section 8 discrimination has thrown the city’s already fragile voucher ecosystem into confusion, raising questions about how or if ...

In case you've faced some hurdles solving the clue, Modify, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...

Data on investigational obexelimab and frexalimab, blood neurofilament light chain as a marker for treatment response, and benefits of ofatumumab are highlighted findings in relapsed-remitting ...